Literature DB >> 7667300

Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones.

S P Whelan1, L A Ball, J N Barr, G T Wertz.   

Abstract

Infectious vesicular stomatitis virus (VSV), the prototypic nonsegmented negative-strand RNA virus, was recovered from a full-length cDNA clone of the viral genome. Bacteriophage T7 RNA polymerase expressed from a recombinant vaccinia virus was used to drive the synthesis of a genome-length positive-sense transcript of VSV from a cDNA clone in baby hamster kidney cells that were simultaneously expressing the VSV nucleocapsid protein, phosphoprotein, and polymerase from separate plasmids. Up to 10(5) infectious virus particles were obtained from transfection of 10(6) cells, as determined by plaque assays. This virus was amplified on passage, neutralized by VSV-specific antiserum, and shown to possess specific nucleotide sequence markers characteristic of the cDNA. This achievement renders the biology of VSV fully accessible to genetic manipulation of the viral genome. In contrast to the success with positive-sense RNA, attempts to recover infectious virus from negative-sense T7 transcripts were uniformly unsuccessful, because T7 RNA polymerase terminated transcription at or near the VSV intergenic junctions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667300      PMCID: PMC41162          DOI: 10.1073/pnas.92.18.8388

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

3.  Amplification, expression, and packaging of foreign gene by influenza virus.

Authors:  W Luytjes; M Krystal; M Enami; J D Parvin; P Palese
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

4.  QB DNA-containing hybrid plasmids giving rise to QB phage formation in the bacterial host.

Authors:  T Taniguchi; M Palmieri; C Weissmann
Journal:  Nature       Date:  1978-07-20       Impact factor: 49.962

5.  Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion.

Authors:  D Baltimore; A S Huang; M Stampfer
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

6.  Cloned poliovirus complementary DNA is infectious in mammalian cells.

Authors:  V R Racaniello; D Baltimore
Journal:  Science       Date:  1981-11-20       Impact factor: 47.728

7.  Vectors for selective expression of cloned DNAs by T7 RNA polymerase.

Authors:  A H Rosenberg; B N Lade; D S Chui; S W Lin; J J Dunn; F W Studier
Journal:  Gene       Date:  1987       Impact factor: 3.688

8.  Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs.

Authors:  A K Pattnaik; G W Wertz
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  Introduction of site-specific mutations into the genome of influenza virus.

Authors:  M Enami; W Luytjes; M Krystal; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

10.  Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA.

Authors:  P Calain; J Curran; D Kolakofsky; L Roux
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

View more
  243 in total

Review 1.  Reverse genetics of negative-strand RNA viruses: closing the circle.

Authors:  A Pekosz; B He; R A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Rescue of mumps virus from cDNA.

Authors:  D K Clarke; M S Sidhu; J E Johnson; S A Udem
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 3.  Reverse genetics approach towards understanding pathogenesis of H5N1 Hong Kong influenza A virus infection.

Authors:  M Hatta; G Neumann; Y Kawaoka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

4.  Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus.

Authors:  S A Kopecky; M C Willingham; D S Lyles
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice.

Authors:  N Ito; M Takayama; K Yamada; M Sugiyama; N Minamoto
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  "Rule of six": how does the Sendai virus RNA polymerase keep count?

Authors:  D Vulliémoz; L Roux
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs.

Authors:  R Flick; R F Pettersson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein.

Authors:  K Juhasz; S S Whitehead; P T Bui; J M Biggs; J E Crowe; C A Boulanger; P L Collins; B R Murphy
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response.

Authors:  E B Flanagan; L A Ball; G W Wertz
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

10.  Genetic inactivation of COPI coatomer separately inhibits vesicular stomatitis virus entry and gene expression.

Authors:  David K Cureton; Rebeca Burdeinick-Kerr; Sean P J Whelan
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.